• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用TRAb Dade试剂盒检测甲状腺疾病患者血清促甲状腺素受体抗体]

[Measurement of serum TSH receptor antibodies in thyroid patients using TRAb Dade kits].

作者信息

Ahmed K, Tomiyoshi K, Fukazawa K, Inoue T, Murakami M, Kobayashi I, Endo K

机构信息

Department of Nuclear Medicine, Gunma University School of Medicine.

出版信息

Kaku Igaku. 1995 Jul;32(7):695-701.

PMID:7674582
Abstract

TRAb Dade kit is a radioreceptor assay that detects autoantibodies in serum of patients with thyroid diseases which interfere with the binding of 125I labeled TSH to its receptor. In this paper we examined the basic and clinical usefulness of newly developed TRAb assay kits. The intra and inter assay coefficients of variation were 7.9% and 8.4%, respectively. There was no significant effect of temperature and incubation time on TRAb values. The influence of conjugated, unconjugated bilirubin, hemoglobin and turbidity was not so significant on TRAb values. TRAb values in serum of 68 untreated Graves' disease were above the normal range, but most (78%) treated Graves' patients who became euthyroid after receiving antithyroid drug, showed the normal range. In patients with chronic renal failure TRAb values were also within the normal range. A significant correlation (y = 1.0x-0.88, r = 0.95) was observed between this TRAb kit and TRAb Cosmic values in various thyroid conditions. This new assay for TRAb was simple, rapid and reproducible. The measurement of serum TRAb values was useful for the evaluation of physiological and pathological function and seemed to be helpful in the management of patients with thyroid disease.

摘要

TRAb Dade试剂盒是一种放射受体分析法,用于检测甲状腺疾病患者血清中的自身抗体,这些自身抗体可干扰125I标记的促甲状腺激素(TSH)与其受体的结合。在本文中,我们研究了新开发的TRAb检测试剂盒的基本特性和临床实用性。该试剂盒的批内和批间变异系数分别为7.9%和8.4%。温度和孵育时间对TRAb值无显著影响。结合胆红素、未结合胆红素、血红蛋白和浊度对TRAb值的影响也不显著。68例未经治疗的格雷夫斯病患者血清中的TRAb值高于正常范围,但大多数(78%)接受抗甲状腺药物治疗后甲状腺功能恢复正常的格雷夫斯病患者,其TRAb值显示在正常范围内。慢性肾功能衰竭患者的TRAb值也在正常范围内。在各种甲状腺疾病状态下,该TRAb试剂盒与TRAb Cosmic值之间观察到显著相关性(y = 1.0x - 0.88,r = 0.95)。这种新的TRAb检测方法简单、快速且可重复。血清TRAb值的测定有助于评估生理和病理功能,似乎对甲状腺疾病患者的管理有帮助。

相似文献

1
[Measurement of serum TSH receptor antibodies in thyroid patients using TRAb Dade kits].[使用TRAb Dade试剂盒检测甲状腺疾病患者血清促甲状腺素受体抗体]
Kaku Igaku. 1995 Jul;32(7):695-701.
2
Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).第二代抗促甲状腺素受体抗体(TRAb)放射免疫分析法在自身免疫性甲状腺疾病中的评估。与第一代抗促甲状腺素受体抗体及抗甲状腺过氧化物酶抗体(AbTPO)的比较。
Q J Nucl Med. 2001 Mar;45(1):115-9.
3
TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.促甲状腺激素受体抗体检测在鉴别甲状腺功能亢进症为格雷夫斯病和多结节毒性甲状腺肿中的应用:两种竞争性结合测定法的比较
Clin Endocrinol (Oxf). 2001 Sep;55(3):381-90. doi: 10.1046/j.1365-2265.2001.01347.x.
4
Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.在格雷夫斯病中,参照甲状腺刺激抗体和甲状腺刺激阻断抗体,对促甲状腺素受体抗体新的不同检测系统进行比较。
Int J Clin Pharmacol Res. 2004;24(4):111-6.
5
Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays.三代 TSH 受体自身抗体检测的敏感性持续提高。
Horm Metab Res. 2010 Nov;42(12):900-2. doi: 10.1055/s-0030-1267171. Epub 2010 Oct 5.
6
Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders.用于评估格雷夫斯病及其他甲状腺疾病患者抗促甲状腺素受体抗体的包被管检测法
Thyroid. 2004 Apr;14(4):295-300. doi: 10.1089/105072504323030951.
7
Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.格雷夫斯病患者在甲巯咪唑治疗前、治疗结束时及停药后的血清促甲状腺素受体抗体浓度:促甲状腺素受体抗体活性和/或甲状腺反应在观察期内发生改变的证据
Thyroid. 2006 Mar;16(3):295-302. doi: 10.1089/thy.2006.16.295.
8
Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test.第二代抗促甲状腺素受体抗体检测在格雷夫斯病中的临床应用。第一代检测为阴性患者的评估。
Clin Chem Lab Med. 2001 Jan;39(1):25-8. doi: 10.1515/CCLM.2001.007.
9
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.停用抗甲状腺药物治疗一个月后进行促甲状腺素和促甲状腺素受体抗体检测,以此作为格雷夫斯病复发的预测指标。
Thyroid. 2005 Sep;15(9):1047-54. doi: 10.1089/thy.2005.15.1047.
10
Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.弥漫性甲状腺自主性或格雷夫斯病:通过第二代促甲状腺激素受体抗体检测进行重新评估。
Thyroid. 2000 Dec;10(12):1073-9. doi: 10.1089/thy.2000.10.1073.

引用本文的文献

1
The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy.妊娠期甲状腺自身抗体的临床价值及变化。
Dis Markers. 2020 Oct 21;2020:8871951. doi: 10.1155/2020/8871951. eCollection 2020.